Business
Falcon Technologies Adds CBD Transdermal Sports Patch to Planned Product Line
Falcon Technologies Adds CBD Transdermal Sports Patch to Planned Product Line.
About this update from Eco-growth Strategies Inc.
[{"type":"text","content":"SACRAMENTO, CA / ACCESSWIRE / May 9, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focused on the marketing, sale, and distribution of CBD products and products derived from industrial hemp announced today that in addition to plans to launch other dermal-delivered CBD products, the company will launch the "CBD Transdermal Sports Patch XR".Over the past few months, Falcon has filed two provisional patents and is also advancing the planned product line for acne, psoriasis and rosacea. These skin conditions represent a very large affected population within the United States.Central to Falcon's business plan is to develop CBD products that deliver therapeutic amounts of CBD with additional product formulation benefits to the customer. Falcon plans on releasing 2 extended release products. One will be a CBD transdermal sports patch. With the "CBD Transdermal Sports Patch XR", CBD is released steadily and consistently over a 24-48 hour period. The other product is an oral extended release product which will release the complete CBD dose steadily over a 12-hour period. Falcon is currently engaged in discussions with 2 other publicly-traded companies regarding the oral product.Universally known as CBD, Cannabidiol (the scientific name for CBD) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.The 2018 Farm Bill legalized industrial hemp, removing this plant rich in CBD and nutritional supplements from the Controlled Substance Act and categorizing it as an agricultural commodity. This bill will allow states to regulate hemp farming while moving the industrialization of the hemp plant forward. As industrial hemp once again becomes one of America's most popular agricultural crops, the amount of CBD processed from the plant will grow exponentially. The hemp-CBD market is projected to grow from $600 million in 2018 to $22 billion by 2022.Over the past 2 months, CVS, one of North America's largest drug store chains began selling topical CBD products.William Delgado, Chairman and Chief Executive Office...